Latest News, Updates & Breaking Headlines
Foreign portfolio investors once again turned towards Dalal Street to shop for Indian equities, spending in Rs 33,487 crore across 15 sectors, in the first half of February. The bulk of the inflows went into capital goods, financial services and oil & gas stocks, marking the strongest fortnightly buying seen since the second half of…
MUMBAI: A day after sensex and Nifty rallied over 1% to recoup most of the losses suffered on the Budget day, indications are that the gains could leapfrog on Tuesday after late on Monday the US President Donald Trump said that the country has reached an agreement with India for a trade deal.Monday evening, Trump…
Market participants said sentiment was further undermined by a shift towards safe-haven assets and persistent foreign fund outflows. (AI image) It’s a bloodbath on Dalal Street! Indian stock market indices, Nifty50 and BSE Sensex, have crashed over 2% this week, leading to investors losing over Rs 16 lakh crore. Even as US President Donald Trump’s…
Experts are of the view that the stock market could see a year-end rally. (AI image) The story of Indian stock markets has been defined by the exodus of foreign investors in 2025. But in the last few sessions, foreign investors seem to be back on Dalal Street, with purchases of Indian equities seeing a…
Stock market outlook: The markets this week were driven by macroeconomic pressures and mixed global cues. Domestically, the rupee slid to a fresh record low of 90.56 against the US dollar, dampening risk sentiment. However, some relief came after the US Federal Reserve announced a 25-basis-point rate cut, while optimism over progress in India–US trade…
On its first day of trading on the stock market, Lenskart’s failed to match the excitement that had built around its IPO in recent weeks.On Monday, the stock listed at Rs 390 on the NSE, entering 3% lower than the issue price of Rs 402. For a company widely regarded as one of India’s most…
Several prominent Indian pharmaceutical firms, including Sun Pharma, Dr. Reddy’s Laboratories, Cipla, Lupin, Aurobindo Pharma, and Zydus Lifesciences, maintain substantial export operations to the USA. (AI image) Pharma stocks hit by Trump’s tariffs: Pharmaceutical stocks declined sharply by up to 5% on Friday, September 26, following US President Donald Trump’s declaration of imposing 100% tariffs…
NEW DELHI: India’s largest tech-enabled home services marketplace, Urban Company, made a blockbuster debut on Dalal Street on Wednesday.The stock listed at Rs 162.25 on NSE, a 57.5% premium over its IPO price of Rs 103. On BSE, the stock opened at Rs 161, up 56.3%, before rallying further to Rs 179, a gain of…
